Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2012 1
2013 1
2014 1
2015 1
2018 2
2021 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean l van dael p[au] (5 results)?
Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Rafferty M, Butt NM, Oh ST, Wortmann F, Ungerstedt J, Guilarte M, Taparia M, Kuykendall AT, Arana Yi C, Ogbogu P, Gaudy-Marqueste C, Mattsson M, Shomali W, Giannetti MP, Bidollari I, Lin HM, Sulllivan E, Mar B, Scherber R, Roche M, Akin C, Maurer M. Gotlib J, et al. Among authors: van daele p. NEJM Evid. 2023 Jun;2(6):EVIDoa2200339. doi: 10.1056/EVIDoa2200339. Epub 2023 May 23. NEJM Evid. 2023. PMID: 38320129 Clinical Trial.
[Idiopathic mast cell activation syndrome].
van Daele PLA, Hermans MAW, Oude Elberink JHNG, van Wijk RG. van Daele PLA, et al. Ned Tijdschr Geneeskd. 2022 Jan 24;166:D5844. Ned Tijdschr Geneeskd. 2022. PMID: 35129899 Dutch.
Commentary: Think anaphylaxis.
van Daele PL. van Daele PL. BMJ. 2009 Mar 9;338:b846. doi: 10.1136/bmj.b846. BMJ. 2009. PMID: 19273525 Free article. No abstract available.
Autoantibodies in Sjögren's syndrome and its classification criteria.
Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ. Veenbergen S, et al. Among authors: van daele pla. J Transl Autoimmun. 2021 Dec 27;5:100138. doi: 10.1016/j.jtauto.2021.100138. eCollection 2022. J Transl Autoimmun. 2021. PMID: 35024595 Free PMC article.
B-cell hyperactivity is a key feature of the disease resulting in the production of a diverse array of autoantibodies in these patients. Although not specific for SS, anti-Ro/SSA and anti-La/SSB antibodies have been useful biomarkers for disease classification and diagnosi …
B-cell hyperactivity is a key feature of the disease resulting in the production of a diverse array of autoantibodies in these patients. Alt …
Sjögren's syndrome: state of the art on clinical practice guidelines.
Romão VC, Talarico R, Scirè CA, Vieira A, Alexander T, Baldini C, Gottenberg JE, Gruner H, Hachulla E, Mouthon L, Orlandi M, Pamfil C, Pineton de Chambrun M, Taglietti M, Toplak N, van Daele P, van Laar JM, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Mariette X. Romão VC, et al. Among authors: van daele p. RMD Open. 2018 Oct 18;4(Suppl 1):e000789. doi: 10.1136/rmdopen-2018-000789. eCollection 2018. RMD Open. 2018. PMID: 30402274 Free PMC article.
Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome.
Both T, Hoorn EJ, Zietse R, van Laar JA, Dalm VA, Brkic Z, Versnel MA, van Hagen PM, van Daele PL. Both T, et al. Among authors: van daele pl. Rheumatology (Oxford). 2015 May;54(5):933-9. doi: 10.1093/rheumatology/keu401. Epub 2014 Oct 29. Rheumatology (Oxford). 2015. PMID: 25354755
RESULTS: The prevalence of complete dRTA (urinary acidification defect with acidosis) was 5% (3/57). All three patients had positive SSA/Ro and SSB/La autoantibodies and impaired kidney function. The prevalence of incomplete dRTA (urinary acidification defect without acido …
RESULTS: The prevalence of complete dRTA (urinary acidification defect with acidosis) was 5% (3/57). All three patients had positive SSA/Ro …
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA. Bodewes ILA, et al. Among authors: van daele pla. J Autoimmun. 2018 Jul;91:97-102. doi: 10.1016/j.jaut.2018.02.001. Epub 2018 Apr 16. J Autoimmun. 2018. PMID: 29673738
13 results